| Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis D Karussis, C Karageorgiou, A Vaknin-Dembinsky, B Gowda-Kurkalli, ... Archives of neurology 67 (10), 1187-1194, 2010 | 1145 | 2010 |
| Identification of tissue-specific cell death using methylation patterns of circulating DNA R Lehmann-Werman, D Neiman, H Zemmour, J Moss, J Magenheim, ... Proceedings of the National Academy of Sciences 113 (13), E1826-E1834, 2016 | 629 | 2016 |
| IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production A Vaknin-Dembinsky, K Balashov, HL Weiner The Journal of Immunology 176 (12), 7768-7774, 2006 | 375 | 2006 |
| Safety and clinical effects of mesenchymal stem cells secreting neurotrophic factor transplantation in patients with amyotrophic lateral sclerosis: results of phase 1/2 and 2a … P Petrou, Y Gothelf, Z Argov, M Gotkine, YS Levy, I Kassis, ... JAMA neurology 73 (3), 337-344, 2016 | 333 | 2016 |
| Humoral and T-cell response to SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab L Brill, A Rechtman, O Zveik, N Haham, E Oiknine-Djian, DG Wolf, N Levin, ... JAMA neurology 78 (12), 1510-1514, 2021 | 158 | 2021 |
| Bone marrow mesenchymal stem cells: agents of immunomodulation and neuroprotection I Kassis, A Vaknin-Dembinsky, D Karussis Current stem cell research & therapy 6 (1), 63-68, 2011 | 145 | 2011 |
| Robot-assisted gait training in multiple sclerosis patients: a randomized trial I Schwartz, A Sajin, E Moreh, I Fisher, M Neeb, A Forest, ... Multiple Sclerosis Journal 18 (6), 881-890, 2012 | 124 | 2012 |
| Oral administration of OKT3 monoclonal antibody to human subjects induces a dose-dependent immunologic effect in T cells and dendritic cells Y Ilan, E Zigmond, G Lalazar, A Dembinsky, A Ben Ya’acov, N Hemed, ... Journal of clinical immunology 30, 167-177, 2010 | 91 | 2010 |
| Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis A Vaknin-Dembinsky, G Murugaiyan, DA Hafler, AL Astier, HL Weiner Journal of neuroimmunology 195 (1-2), 140-145, 2008 | 76 | 2008 |
| A nasal proteosome adjuvant activates microglia and prevents amyloid deposition D Frenkel, L Puckett, S Petrovic, W Xia, G Chen, J Vega, ... Annals of neurology 63 (5), 591-601, 2008 | 63 | 2008 |
| Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosis KE Balashov, LL Aung, A Vaknin‐Dembinsky, S Dhib‐Jalbut, HL Weiner Annals of neurology 68 (6), 899-906, 2010 | 60 | 2010 |
| Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial T Chitnis, B Banwell, L Kappos, DL Arnold, K Gücüyener, K Deiva, ... The Lancet Neurology 20 (12), 1001-1011, 2021 | 59 | 2021 |
| In vitro induction of regulatory T cells by anti-CD3 antibody in humans M Abraham, A Karni, A Dembinsky, A Miller, R Gandhi, D Anderson, ... Journal of autoimmunity 30 (1-2), 21-28, 2008 | 58 | 2008 |
| Description of 3 patients with myasthenia gravis and COVID-19 N Rein, N Haham, E Orenbuch-Harroch, M Romain, Z Argov, ... Journal of the Neurological Sciences 417, 117053, 2020 | 54 | 2020 |
| Familial Mediterranean fever (FMF) and multiple sclerosis: an association study in one of the world’s largest FMF cohorts G Yahalom, S Kivity, M Lidar, A Vaknin‐Dembinsky, D Karussis, ... European Journal of Neurology 18 (9), 1146-1150, 2011 | 53 | 2011 |
| Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population A Vaknin-Dembinsky, L Brill, N Orpaz, O Abramsky, D Karussis Multiple Sclerosis Journal 16 (12), 1453-1457, 2010 | 53 | 2010 |
| Myasthenia gravis–associated neuromyelitis optica–like disease: an immunological link between the central nervous system and muscle? A Vaknin-Dembinsky, O Abramsky, P Petrou, T Ben-Hur, M Gotkine, L Brill, ... Archives of neurology 68 (12), 1557-1561, 2011 | 50 | 2011 |
| T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial D Karussis, H Shor, J Yachnin, N Lanxner, M Amiel, K Baruch, ... PloS one 7 (12), e50478, 2012 | 48 | 2012 |
| Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14 Z Ochanuna, A Geiger-Maor, A Dembinsky-Vaknin, D Karussis, ... PloS one 5 (9), e12868, 2010 | 44 | 2010 |
| Mutation-specific pathophysiological mechanisms define different neurodevelopmental disorders associated with SATB1 dysfunction J Den Hoed, E de Boer, N Voisin, AJM Dingemans, N Guex, L Wiel, ... The American Journal of Human Genetics 108 (2), 346-356, 2021 | 42 | 2021 |
Dimitrios KarussisProfessor of Neurology, Hebrew University, Jerusalem, IsraelVerified email at hadassah.org.il
